Physician Assistants
Offices
Hospital Affiliations
Contact Us
Links
Hipaa

Construction around the Dallas office is making parking scarce.  Please plan for more time than normal when coming to your appointment at the Dallas office.

 

Education:  Fellowship:
Orthopaedic Surgery, Adult Reconstruction: The
University of Colorado Health Science Center; Denver, Colorado 1993-1994.

Residency:
Orthopaedic Surgery: University of Texas Southwestern
Medical School; Dallas, Texas – 1989-1993.

Internship:
General Surgery: University of Texas Southwestern
Medical School; Dallas, Texas – 1988-1989.

Medical School:
University of Texas Health Science Center, San
Antonio, Texas – 1984-1988. Degree: Doctor of Medicine

College:
Texas A&M University; College Station, Texas – 1980-1984.
Degree: None.

High School:
Richard King High School; Corpus Christi, Texas – 1977-1980.
Licensure:  Texas State Board of Medical Examiners. 1989-Present
Colorado State Board of Medical Examiners. 1993-Present
Certification:  American Board of Orthopaedic Surgeons. July 1996.
Privileges:  Presbyterian Hospital of Dallas, Staff Orthopaedic Surgeon, Active.
Presbyterian Hospital of Plano, Staff Orthopaedic Surgeon, Active.
Presbyterian Hospital of Kaufman, Dept. of Orthopaedic Surgery, Prov. Courtesy.
Department of Veteran Affairs Medical Center; Dallas, Texas; Consultant
Physician in Orthopaedic Surgery – 1995- 1998.
Parkland Memorial Hospital; Dallas, Texas; Clinical Assistant Professor of Orthopaedic Surgery – 1994-Present.
Teaching
Appointments:		 University of Texas Southwestern Medical School; Dallas, Texas
Clinical Assistant Professor of Orthopaedic Surgery – 1994-Present. 
University of North Texas Health Science Center; Fort Worth, Texas 
Adjunct Faculty, Preceptor – 11/19/99-Present.
Department of Veteran Affairs Medical Center; Dallas, Texas. Consultant
Physician in Orthopaedic Surgery – 1995-Present.
University of Colorado Health Science Center; Fellow and Instructor,
Department of Orthopaedic Surgery – 1993-1994.
Department of Veteran Affairs Medical Center, Denver, Colorado,
Instructor, Orthopaedic Surgery – 1993-1994.
Texas Women’s University, Adjunct Professor – 1990-1993.
Appointments:  President of Medical Staff, Presbyterian Hospital of Wylie – 1998-1999.
Honors /Awards:  Valedictorian, University of Texas Health Science Center; San Antonio, 
Texas (Medical School) 1988.
Alpha Omega Alpha Medical Honor Society – 1987 as a junior student.
Phi Kappa Phi Honor Society – 1983.
Beta Beta Beta Biological Honor Society – 1983.
Valedictorian – Richard King High School – 1980.
Runner-up, South Texas Athlete of the Year – 1980.
All-District Basketball Team – 1979-1980.
All-District Baseball Team – 1979-1980.
National Honor Society – 1979-1980.
Publications:  Heckman, James D., and Champine, Michael J.: New Techniques in the
Management of Foot Trauma. Clin. Orthop. 240: 105, 1989.

Schlegel, John D.; Champine, Julie; Taylor, Michelle S.; Watson, Jeffrey 
T.; Champine, Mike; Schleusener, Rand L.; and Savory, Kevin M.:
The Role of Distraction in Improving the Space Available in the 
Lumbar Stenotic Canal and Foramen. Spine. 19(18): 2041, 1994.

Champine, Michael J.: Proximal Femoral Strut Grafts in Revision Total 
Hip Arthroplasty. In press.

Champine, Michael J.: Total Hip Revision Arthroplasty Using a Modular 
Prosthesis. In press.
Research: 

 

 

 

 
  1. SR90107A/ORG 31540
    6/1997 - 9/1997 (Completed)
    Position: Sub-investigator 
    Sponsor: Sanofi Research 
    Trial: Phase II Dose finding and safety study of a DVT prophylaxis drug in post-operative primary unilateral total hip replacement patients.
  2. SR90107A/ORG 31540
    12/1998 - 11/1999 (Completed)
    Position: Sub-investigator 
    Sponsor: Sanofi Research 
    Trial: Phase III Comparison for efficacy and safety of two DVT prophylaxis drugs in post-operative primary, or revision, unilateral total hip replacement patients.
  3. SR90107A/ORG 31540
    3/1999 – 11/1999 (Completed)
    Position: Sub-investigator 
    Sponsor: Organon, Inc 
    Trial: Phase III Comparison for efficacy and safety of two DVT prophylaxis drugs in post-operative primary, or revision, unilateral total knee replacement patients. 
  4. Protocol 236
    4/2000 – 8/2000 (Completed)
    Position: Sub-investigator and Investigators’ Meeting Designate 
    Sponsor: AstraZeneca Pharmaceuticals
    Trial: Phase III Comparison for efficacy and safety of two DVT
    prophylaxis drugs in post-operative primary unilateral, or bilateral, total knee replacement patients. 
  5. Protocol 237
    4/2000 – 1/2001 (Completed)
    Position: Sub-investigator and Investigators’ Meeting Designate 
    Sponsor: AstraZeneca Pharmaceuticals 
    Trial: Phase III Comparison for efficacy and safety of two DVT
    prophylaxis drugs in post-operative primary unilateral total hip 
    replacement patients. 
  6. SR 90107A/ORG 31540:
    8/2000 – 9/2001 (Completed)
    Position: Sub-investigator
    Sponsor: Sanofi-Synthelabo Research
    Trial: Phase III Comparison for safety and efficacy of two drugs in the treatment of acute symptomatic DVT.
  7. VP 104
    8/2000 – 2/2001 (Completed) 
    Position: Principal Investigator 
    Sponsor: Knoll Pharmaceuticals
    Trial: Comparison of the efficacy and safety of vicoprofen vs. oxycodone 
    in post-operative ACL Repair patients.
  8. Protocol #HCD2001 (Cohort 1)
    Protocol #HCD2001 (Cohort 2)
    3/2001 – 2/2002 (Completed)
    Position: Investigator
    Sponsor: Purdue Pharma L.P.
    Trial: A single dose two cohort (open-label sequential groups/double blind placebo-controlled parallel groups) trial designed to evaluate the efficacy and safety of a single dose of 15, 30, or 45 mg. extended-release hydrocodone (HCD) in post operative orthopaedic patients.
  9. PROTECT TRIAL
    5/2001 – 1/2002 (Completed)
    Position: Sub-investigator
    Sponsor: Emisphere Technologies
    Trial: Phase III Comparison study of two doses of SNAC/heparin vs. enoxaparin in total hip replacement surgery.
  10. Protocol 538 DPC 906/201
    10/2001 – Present
    Position: Sub-investigator
    Sponsor: DuPont Pharmaceuticals Company/Bristol Myers Squibb
    Trial: PhaseII Randomized, double-blind, active-controlled (Enoxaparin), parallel group, dose-response study of DPC 906/201 for the prevention of deep venous thrombosis in knee replacement surgery.
  11. P. 543 EXULT Knee
    10/2001 – Present
    Position: Sub-investigatossr
    Sponsor: Astra-Zeneca L.P.
    Trial: Optimization of dose (Study A) and confirmation of safety and efficacy (Study B) of H 376/95 (Oral direct thrombin inhibitor) compared to warfarin (Coumadinâ) for the prevention of thromboembolism following total knee arthroplasty 9TKA). Protocol Number 290.
  12. HCD 2002
    3/2002 – Present
    Position: Investigator
    Sponsor: Purdue Pharma L.P.
    Trial: A single dose two cohort (open-label sequential groups/double blind placebo-controlled parallel groups) trial designed to evaluate the efficacy and safety of a single dose of 15, 30, or 45 mg. extended-release hydrocodone (HCD) in post operative orthopaedic patients.
Presentations: 

 

 

 June 16, 1993. The Role of Distraction in Improving the Space Available
In the Lumbar Stenotic Canal and Foramen. Champine, Mike; 
Schlegel, John D.; Champine, Julie; Taylor, Michelle S.; Watson,
Jeffrey T.; Schleusener, Rand L.; and Savory, Kevin M. Presented at 
The International Society for the Study of the Lumbar Spine. 
Versailles, France.

October 16, 1993. The Role of Distraction in Improving the Space 
Available in the Lumbar Stenotic Canal and Foramen. Champine,
Mike; Schlegel, John D.; Champine, Julie; Taylor, Michelle S.; 
Watson, Jeffrey T.; Schleusener, Rand L.; and Savory, Kevin M.
Presented at The North American Spine Meeting. San Diego, 
California.

January 25, 1994. DVT Prophylaxis in Reconstructive Surgery of the 
Hip and Knee. Presented at Reconstructive Surgery of the Hip and
Knee. Steamboat Springs, Colorado.
March 15, 1995. DVT Prophylaxis in Reconstructive Surgery of the Hip
And Knee. Presented at Reconstructive Surgery of the Hip and Knee.
Telluride, Colorado.

January 1996. Hip Fractures. Presented at Merck Symposium on 
Osteoporosis. Dallas, Texas.
March 1, 1996. DVT Prophylaxis. Presented at Reconstructive Surgery
of the Hip and Knee. Aspen, Colorado.

September 10, 1996. Joint Replacement Surgery. Presented to Dallas 
American Association of Operating Room Nurses. Dallas, Texas.

October 16, 1996. DVT Prophylaxis. Presented at Rhone-Poulenc Rorer
Symposium on DVT. Austin, Texas.

May, 1997. What’s New in Joint Replacement Surgery? Presented at The
Texas State Physical Therapy Association State Meeting. Dallas, 
Texas.

May, 1999. Alternatives to Joint Replacement Surgery. Presented at The
Texas State Physical Therapy Association State Meeting. Dallas,
Texas.

October 14, 2000. Arthritis and Total Joint Replacement of the Hip and 
Knee. Presented at the Arthritis Foundation Allied Health Professionals Clinical Symposium. Dallas, Texas.

November 15, 2001. Pentasaccharide (Fondaparinux): A Novel Factor Xa Inhibitor that is Superior to Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism After Orthopedic Surgery. Peters, Paul C.; Champine, Michael J.; and Vengrow, Lucy Smith. Presented at The American Association of Hip and Knee Surgeons Annual Meeting. Dallas, Texas.

February 14, 2002. Interdisciplinary Fracture Treatment (Hip Fracture): Medical Treatment. Presented at The 69th Annual American Academy of Orthopaedic Surgeons Meeting, Nursing and Allied Health Program. Dallas, Texas.

February 14, 2002. Complications of Hip Fracture. Presented at The 69th Annual American Academy of Orthopaedic Surgeons Meeting, Nursing and Allied Health Program. Dallas, Texas.
Memberships:  American Academy of Orthopedic Surgeons
American Association of Orthopedic Surgeons
American Society of Orthopedic Surgeons
Texas Orthopedic Association
American Association of Hip and Knee Surgeons
American Medical Association
Texas Medical Association
Texas Medical Foundation
Dallas County Medical Society
Employment: 

 

 

 Texas Orthopaedic Associates, Orthopaedic Surgeon, 8210 Walnut Hill Lane, Suite 130, Dallas, Texas 75231 – 1994-Present.

University of Colorado Health Science Center, Fellow and Instructor, 
Department of Orthopaedic Surgery – 1993-1994.

Department of Veteran Affairs Medical Center, Denver, Colorado,
Instructor, Orthopaedic Surgery – 1993-1994.

Dallas County Hospital District, Resident, Parkland Memorial Hospital-
1988-1993.

Texas Women’s University, Adjunct Professor - 1990-1993.

Team Physician, Wilmer-Hutchins High School Football Team – 1991; St. Marks School of Dallas – 1994-1995; Wylie Independent School District – 1996-Present.

McDonald and Miller Mechanical Contracting Company, Plumbing 
Assistant – 1975-1986.

Texas A&M University, Resident Advisor – 1982-1984.
Activities:  Basketball
Golf
Downhill Skiing
Woodwork
Home Repair

 

 

© Copywrite, Texas Orthopaedic Associates, L.L.P., 2007